First-Lot QA Checklist for Peptide API Buyers
A practical first-lot review checklist for pharmacy QA teams qualifying peptide API before recurring supply.
Published May 26, 2026 · 5 min read · By Vialdyne Regulatory Team
The first peptide API lot is where pharmacy QA learns whether a supplier's documentation chain is real. The review should happen before recurring volume is promised, because the first lot establishes the analytical scope, traceability expectations, and deviation-response cadence for every later order.
What should be in a first-lot QA checklist for peptide API?
A first-lot QA checklist should start with the matching batch COA and review the identity, methods, specifications, and results actually recorded there. Storage, shipment, retain-sample, deviation-response, and audit-support expectations should be agreed in writing; any additional testing is optional unless the buyer's own procedure requires it.
First-lot review items
- Lot number, manufacture date, retest date, storage condition, and signed release decision
- HPLC chromatogram with method conditions and integration table
- Mass-spec identity report and, for long peptides, sequence-level evidence when needed
- Counter-ion, water content, residual solvents, and appearance
- LAL endotoxin and USP microbial limits where the route or pathway requires them
- Stability summary or study availability for inventory planning
- Retain-sample policy, OOS/deviation response path, and supplier QA contact
Decision rule
Accept the first lot only if the supplier can connect the documents to the exact shipped batch and answer method questions in writing. If a document is representative rather than lot-specific, record that explicitly and decide whether the workflow can tolerate that evidence level before scaling.
Talk to our regulatory team
Reviewing a first peptide API lot?
Tell us the molecule, required documents, and any optional tests your written procedure calls for. QA will map the scope before quotation.
Frequently asked questions
- What should be in a first-lot QA checklist for peptide API?
- Start with the matching batch COA and review the lot identity, methods, specifications, and results actually recorded there. Agree storage, shipment, retain-sample, deviation-response, and audit-support expectations in writing. Additional testing is optional unless the buyer's own procedure requires it.
- When should a pharmacy review the first peptide API lot?
- Before recurring volume is promised, review the offered lot's batch COA and agree the documentation, traceability, and deviation-response expectations for later orders. This review does not by itself require the buyer to duplicate release testing.
- When is it acceptable to accept a first peptide API lot?
- Accept the first lot only if the supplier can connect the documents to the exact shipped batch and answer method questions in writing. If a document is representative rather than lot-specific, record that explicitly and decide whether the workflow can tolerate that evidence level before scaling.